Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance Abuse, Intravenous | 20 | 2022 | 128 | 6.020 |
Why?
|
| Sexual Partners | 21 | 2021 | 325 | 3.520 |
Why?
|
| HIV Infections | 27 | 2024 | 2535 | 2.370 |
Why?
|
| Opioid-Related Disorders | 3 | 2025 | 188 | 1.740 |
Why?
|
| Pregnancy Complications | 3 | 2021 | 134 | 1.580 |
Why?
|
| Sexual Behavior | 14 | 2019 | 634 | 1.570 |
Why?
|
| Neonatal Abstinence Syndrome | 2 | 2021 | 14 | 1.260 |
Why?
|
| Risk-Taking | 14 | 2021 | 456 | 1.210 |
Why?
|
| Mexico | 21 | 2018 | 286 | 1.110 |
Why?
|
| Violence | 4 | 2022 | 133 | 1.080 |
Why?
|
| Prenatal Care | 2 | 2018 | 82 | 1.030 |
Why?
|
| Adult | 39 | 2025 | 13437 | 1.020 |
Why?
|
| Kenya | 8 | 2022 | 56 | 1.010 |
Why?
|
| Substance-Related Disorders | 7 | 2021 | 825 | 1.000 |
Why?
|
| Qualitative Research | 13 | 2019 | 523 | 0.920 |
Why?
|
| Fentanyl | 1 | 2025 | 16 | 0.910 |
Why?
|
| Female | 42 | 2025 | 23980 | 0.880 |
Why?
|
| Interpersonal Relations | 9 | 2018 | 216 | 0.850 |
Why?
|
| Syringes | 2 | 2021 | 7 | 0.810 |
Why?
|
| Needle-Exchange Programs | 2 | 2021 | 12 | 0.800 |
Why?
|
| California | 9 | 2025 | 531 | 0.800 |
Why?
|
| Unsafe Sex | 8 | 2018 | 162 | 0.800 |
Why?
|
| Heroin | 3 | 2018 | 18 | 0.790 |
Why?
|
| Central Nervous System Stimulants | 1 | 2025 | 180 | 0.790 |
Why?
|
| Analgesics, Opioid | 1 | 2025 | 245 | 0.760 |
Why?
|
| Public Health | 4 | 2024 | 405 | 0.760 |
Why?
|
| Humans | 52 | 2025 | 42113 | 0.750 |
Why?
|
| Health Personnel | 3 | 2021 | 262 | 0.730 |
Why?
|
| Young Adult | 19 | 2025 | 4928 | 0.720 |
Why?
|
| Methamphetamine | 6 | 2025 | 166 | 0.700 |
Why?
|
| Heroin Dependence | 2 | 2018 | 23 | 0.700 |
Why?
|
| Buprenorphine | 1 | 2021 | 51 | 0.660 |
Why?
|
| Sexually Transmitted Diseases | 7 | 2018 | 172 | 0.650 |
Why?
|
| Drug Users | 4 | 2022 | 51 | 0.640 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2017 | 959 | 0.640 |
Why?
|
| Male | 33 | 2025 | 22745 | 0.590 |
Why?
|
| Commerce | 2 | 2019 | 95 | 0.590 |
Why?
|
| Perinatal Care | 1 | 2018 | 14 | 0.590 |
Why?
|
| Postnatal Care | 1 | 2018 | 16 | 0.580 |
Why?
|
| Health Services Accessibility | 4 | 2022 | 680 | 0.580 |
Why?
|
| Interviews as Topic | 10 | 2019 | 427 | 0.550 |
Why?
|
| Spouses | 1 | 2017 | 38 | 0.530 |
Why?
|
| Crime | 1 | 2017 | 29 | 0.520 |
Why?
|
| United States | 12 | 2024 | 5068 | 0.510 |
Why?
|
| Family Characteristics | 3 | 2017 | 124 | 0.490 |
Why?
|
| Love | 1 | 2015 | 6 | 0.470 |
Why?
|
| Decision Making | 1 | 2017 | 242 | 0.450 |
Why?
|
| Social Sciences | 1 | 2014 | 6 | 0.440 |
Why?
|
| Trust | 2 | 2017 | 157 | 0.440 |
Why?
|
| Needle Sharing | 3 | 2021 | 11 | 0.400 |
Why?
|
| Adolescent | 10 | 2025 | 5949 | 0.390 |
Why?
|
| Research | 1 | 2014 | 177 | 0.390 |
Why?
|
| Anti-HIV Agents | 1 | 2017 | 475 | 0.390 |
Why?
|
| Harm Reduction | 2 | 2024 | 27 | 0.360 |
Why?
|
| Condoms | 6 | 2014 | 148 | 0.350 |
Why?
|
| Adaptation, Psychological | 2 | 2018 | 410 | 0.340 |
Why?
|
| Drug and Narcotic Control | 1 | 2010 | 11 | 0.330 |
Why?
|
| Anti-Infective Agents | 3 | 2018 | 74 | 0.330 |
Why?
|
| Population Surveillance | 1 | 2012 | 245 | 0.330 |
Why?
|
| Ohio | 2 | 2021 | 17 | 0.320 |
Why?
|
| Data Collection | 4 | 2016 | 210 | 0.310 |
Why?
|
| Pregnancy | 3 | 2021 | 1733 | 0.300 |
Why?
|
| Bariatric Surgery | 2 | 2018 | 20 | 0.290 |
Why?
|
| Obesity, Morbid | 2 | 2018 | 29 | 0.280 |
Why?
|
| Prevalence | 9 | 2022 | 1593 | 0.280 |
Why?
|
| Mass Screening | 1 | 2012 | 531 | 0.270 |
Why?
|
| Homosexuality, Male | 3 | 2018 | 483 | 0.260 |
Why?
|
| Middle Aged | 12 | 2025 | 11790 | 0.260 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2018 | 470 | 0.250 |
Why?
|
| Infant, Newborn | 2 | 2021 | 960 | 0.250 |
Why?
|
| Socioeconomic Factors | 6 | 2018 | 1221 | 0.240 |
Why?
|
| Alcoholism | 2 | 2018 | 292 | 0.220 |
Why?
|
| Amphetamine-Related Disorders | 2 | 2015 | 69 | 0.210 |
Why?
|
| Risk Factors | 9 | 2021 | 3933 | 0.200 |
Why?
|
| Pharmaceutical Preparations | 2 | 2024 | 93 | 0.200 |
Why?
|
| Feminism | 1 | 2022 | 3 | 0.190 |
Why?
|
| Social Support | 3 | 2014 | 437 | 0.190 |
Why?
|
| Soft Tissue Infections | 1 | 2021 | 6 | 0.180 |
Why?
|
| Aggression | 1 | 2022 | 101 | 0.180 |
Why?
|
| Africa South of the Sahara | 3 | 2019 | 51 | 0.170 |
Why?
|
| Methadone | 1 | 2021 | 24 | 0.170 |
Why?
|
| Sex Factors | 2 | 2015 | 1004 | 0.170 |
Why?
|
| Hepatitis C | 1 | 2022 | 138 | 0.170 |
Why?
|
| Negotiating | 2 | 2017 | 26 | 0.160 |
Why?
|
| Pharmaceutical Services | 1 | 2019 | 23 | 0.150 |
Why?
|
| Rectum | 1 | 2018 | 27 | 0.150 |
Why?
|
| Cross-Sectional Studies | 4 | 2015 | 3073 | 0.140 |
Why?
|
| Role | 1 | 2017 | 10 | 0.140 |
Why?
|
| Telemedicine | 1 | 2021 | 214 | 0.140 |
Why?
|
| Feasibility Studies | 2 | 2024 | 238 | 0.130 |
Why?
|
| Safe Sex | 1 | 2017 | 78 | 0.130 |
Why?
|
| Photography | 1 | 2017 | 48 | 0.130 |
Why?
|
| Gender Identity | 1 | 2017 | 117 | 0.130 |
Why?
|
| Reproductive Health Services | 1 | 2016 | 14 | 0.130 |
Why?
|
| Behavior, Addictive | 1 | 2017 | 37 | 0.130 |
Why?
|
| Income | 1 | 2017 | 160 | 0.130 |
Why?
|
| Postoperative Complications | 1 | 2018 | 253 | 0.120 |
Why?
|
| Alcohol Drinking | 2 | 2018 | 585 | 0.120 |
Why?
|
| Anthropology, Cultural | 1 | 2016 | 12 | 0.120 |
Why?
|
| Drug Contamination | 1 | 2016 | 11 | 0.120 |
Why?
|
| Vulnerable Populations | 2 | 2014 | 163 | 0.120 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 188 | 0.110 |
Why?
|
| Contact Tracing | 1 | 2014 | 22 | 0.110 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 222 | 0.110 |
Why?
|
| Medically Underserved Area | 1 | 2015 | 118 | 0.110 |
Why?
|
| Public Policy | 1 | 2014 | 36 | 0.110 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 570 | 0.110 |
Why?
|
| Research Subjects | 1 | 2014 | 34 | 0.110 |
Why?
|
| Prisoners | 1 | 2015 | 95 | 0.100 |
Why?
|
| HIV Seropositivity | 1 | 2015 | 196 | 0.100 |
Why?
|
| Truth Disclosure | 1 | 2013 | 26 | 0.100 |
Why?
|
| Risk Reduction Behavior | 1 | 2014 | 137 | 0.100 |
Why?
|
| Cocaine | 1 | 2016 | 248 | 0.100 |
Why?
|
| Patient Compliance | 1 | 2014 | 225 | 0.100 |
Why?
|
| Eligibility Determination | 1 | 2012 | 9 | 0.090 |
Why?
|
| Sample Size | 1 | 2012 | 28 | 0.090 |
Why?
|
| Clinical Protocols | 1 | 2012 | 36 | 0.090 |
Why?
|
| Substance Abuse Detection | 1 | 2012 | 31 | 0.090 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2012 | 51 | 0.090 |
Why?
|
| Attitude to Health | 1 | 2014 | 335 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2014 | 1570 | 0.090 |
Why?
|
| Child | 2 | 2017 | 3381 | 0.090 |
Why?
|
| Age Factors | 1 | 2014 | 1135 | 0.090 |
Why?
|
| Communication | 1 | 2013 | 207 | 0.090 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2010 | 21 | 0.080 |
Why?
|
| Patient Selection | 1 | 2012 | 192 | 0.080 |
Why?
|
| Aged | 2 | 2019 | 7958 | 0.080 |
Why?
|
| Program Development | 1 | 2010 | 237 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2014 | 1728 | 0.080 |
Why?
|
| Crime Victims | 2 | 2018 | 77 | 0.060 |
Why?
|
| Family Relations | 2 | 2015 | 46 | 0.050 |
Why?
|
| Hepatitis C Antibodies | 1 | 2022 | 10 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2022 | 71 | 0.050 |
Why?
|
| Abscess | 1 | 2021 | 10 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2022 | 73 | 0.040 |
Why?
|
| Police | 1 | 2020 | 17 | 0.040 |
Why?
|
| Self Care | 1 | 2021 | 173 | 0.040 |
Why?
|
| Policy Making | 1 | 2019 | 35 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2018 | 33 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2019 | 335 | 0.030 |
Why?
|
| Health Policy | 1 | 2019 | 184 | 0.030 |
Why?
|
| Jealousy | 1 | 2015 | 2 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 1051 | 0.030 |
Why?
|
| Homicide | 1 | 2015 | 17 | 0.030 |
Why?
|
| Women | 1 | 2014 | 28 | 0.030 |
Why?
|
| Spouse Abuse | 1 | 2014 | 51 | 0.030 |
Why?
|
| Vagina | 1 | 2014 | 89 | 0.030 |
Why?
|
| Sex Offenses | 1 | 2014 | 43 | 0.030 |
Why?
|
| Prejudice | 1 | 2014 | 116 | 0.030 |
Why?
|
| Administration, Intravaginal | 1 | 2013 | 8 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 163 | 0.020 |
Why?
|
| Counseling | 1 | 2014 | 134 | 0.020 |
Why?
|
| Evidence-Based Practice | 1 | 2013 | 48 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2014 | 584 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2014 | 357 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1052 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1019 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 1142 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 1515 | 0.020 |
Why?
|